Paper
Polygenic Risk Scores in Prostate Cancer Risk Assessment and Screening.
Published Aug 1, 2021 · Lindsey Byrne, A. Toland
The Urologic clinics of North America
Q2 SJR score
9
Citations
1
Influential Citations
Abstract
Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Study Snapshot
Polygenic risk scores show promise in identifying individuals at higher or lower prostate cancer risk, improving prostate-specific antigen screening, and potentially guiding screening ages and aggressive tumor development.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
Sign up to use Study Snapshot
Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.
Full text analysis coming soon...
References
Validation of a prostate cancer polygenic risk score
The prostate cancer polygenic risk score (PRS) accurately predicts prostate cancer risk based on a combination of SNPs, providing a valuable tool for risk stratification.
2020·28citations·M. Black et al.·The Prostate
The Prostate
A discussion on controversies and ethical dilemmas in prostate cancer screening
Prostate cancer screening reduces cancer-specific mortality but may impact quality of life due to overdiagnosis and overtreatment.
2020·13citations·S. Mishra·Journal of Medical Ethics
Journal of Medical Ethics
Prediction models for prostate cancer to be used in the primary care setting: a systematic review
A few prostate cancer risk prediction models can be readily used in primary healthcare or community health settings, but further studies are needed to improve their clinical utility for prostate testing in community settings.
2020·23citations·Mohammad Aladwani et al.·BMJ Open
BMJ Open
Association of a Polygenic Risk Score With Breast Cancer Among Women Carriers of High- and Moderate-Risk Breast Cancer Genes
The 86-single-nucleotide variation score may modify breast cancer risk for carriers of BRCA1, BRCA2, CHEK2, ATM, and PALB2 pathogenic variants.
2020·93citations·S. Gallagher et al.·JAMA Network Open
JAMA Network Open
A Genetic Risk Score to Personalize Prostate Cancer Screening, Applied to Population Data
The polygenic hazard score (PHS) can personalize prostate cancer screening decisions by providing individualized estimates of risk-equivalent age for clinically significant prostate cancer.
2020·27citations·M. Huynh-Le et al.·Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
A Genetic Risk Score to Personalize Prostate Cancer Screening, Applied to Population Data
The polygenic hazard score (PHS) can personalize prostate cancer screening decisions by providing individualized estimates of risk-equivalent age for clinically significant prostate cancer.
2020·11citations·Minh-Phuong Huynh-Le et al.·Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
Citations
Genome‑wide association study and polygenic risk scores predict psoriasis and its shared phenotypes in Taiwan
Several genetic loci significantly contribute to psoriasis susceptibility in Taiwanese individuals, providing valuable insights into the underlying etiology of psoriasis in the Taiwanese community.
2024·2citations·Jai-Sing Yang et al.·Molecular Medicine Reports
Molecular Medicine Reports
Dose outside of the prostate is associated with improved outcomes for high-risk prostate cancer patients treated with brachytherapy boost
Higher doses outside the prostate in high-risk prostate cancer patients treated with brachytherapy boost are associated with lower biochemical recurrence rates, influenced by age and T-stage.
2023·1citation·J. Shortall et al.·Frontiers in Oncology
Frontiers in Oncology
How do experts in psychiatric genetics view the clinical utility of polygenic risk scores for schizophrenia?
Polygenic risk scores (PRS) are not yet robust enough for assessing schizophrenia susceptibility, but 89.8% of psychiatric genetics experts are optimistic about their use in the next 10 years.
2023·3citations·Tiahna Moorthy et al.·American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
The Combined Effect of Polygenic Risk Score and Prostate Health Index in Chinese Men Undergoing Prostate Biopsy
The combination of polygenic risk score and prostate health index significantly improves prostate cancer diagnosis in Chinese men undergoing prostate biopsy.
2023·2citations·Xiaohao Ruan et al.·Journal of Clinical Medicine
Journal of Clinical Medicine
Polygenic risk score in prostate cancer
Polygenic risk score (PRS) may add predictive value to prostate cancer risk estimation, but a large-scale, well-validated model is needed for clinical practice.
2022·5citations·J. Oh et al.·Current Opinion in Urology
Current Opinion in Urology